Word

PRL

Status

Pending

Status Code

638

Status Date

Friday, April 26, 2024

Serial Number

98214461

Mark Type

4

Filing Date

Monday, October 9, 2023

Trademark Owner History

ReNAgade Therapeutics Management, Inc.

Classifications

5 Pharmaceutical preparations, lipids, lipid nanoparticles, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds/agents for medical use; pharmaceutical preparations and therapeutic agents, namely, for RNA, gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation

1 Chemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticles, lipid formulations, nucleic acids and modified nucleic acids, including short RNAs and messenger RNAs; nucleic acid sequences for scientific purposes, research purposes, and laboratory purposes other than medical and veterinary purposes

42 Research and development in the field of technology and engineering, lipids, lipid nanoparticles, lipid formulations and RNAs for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of lipids, lipid nanoparticles, lipid formulations, RNAs, namely, developing molecular and cellular biology reagents, techniques, and assays for use in pharmaceutical and biomedical industry

Trademark Events

Apr 26, 2024

Assigned To Examiner

Oct 12, 2023

New Application Entered

Oct 15, 2023

New Application Office Supplied Data Entered